The pharmaceutical landscape is witnessing a change with the emergence of GLP-1 transdermal systems . These innovative formulations offer a promising alternative to providing glucagon-like peptide-1 drugs https://robertxuyx131297.myparisblog.com/41490541/glp-1-patches-a-new-way-to-control-blood-sugar